β-Casein nanoparticle-based oral drug delivery system for potential treatment of gastric carcinoma: Stability, target-activated release and cytotoxicity

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 80, Issue 2, 2012, Pages 298-305

  Shapira, Alina ^a   Davidson, Irit ^a   Avni, Noa ^a   Assaraf, Yehuda G ^a   Livney, Yoav D ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Casein; Chemotherapy; Drug targeting; Nanoparticles; Oral delivery; Paclitaxel

Indexed keywords

BETA CASEIN; BETA CASEIN NANOPARTICLE; NANOPARTICLE; PACLITAXEL; PEPSIN A; UNCLASSIFIED DRUG;

CHEEK; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXICITY; DIGESTION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG STABILITY; ESOPHAGUS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYDROPHOBICITY; NANOENCAPSULATION; STOMACH CARCINOMA; TRANSMISSION ELECTRON MICROSCOPY;

ADMINISTRATION, ORAL; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CASEINS; CELL LINE, TUMOR; CRYSTALLIZATION; DIMETHYL SULFOXIDE; DRUG DELIVERY SYSTEMS; DRUG STABILITY; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; INHIBITORY CONCENTRATION 50; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PACLITAXEL; STOMACH NEOPLASMS;

EID: 84856607406     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2011.10.022     Document Type: Conference Paper

References (33)

1. L. Vecchione, M. Orditura, F. Ciardiello, and F. De Vita Novel investigational drugs for gastric cancer Expert Opin. Invest. Drugs 18 2009 945 955
2. G. Liu, E. Franssen, M.I. Fitch, and E. Warner Patient preferences for oral versus intravenous palliative chemotherapy J. Clin. Oncol. 15 1997 110 115 (Pubitemid 27021524)
3. C. Wischke, and H.H. Borchert Increased sensitivity of chitosan determination by a dye binding method Carbohydr. Res. 341 2006 2978 2979
4. A. Shapira, Y.G. Assaraf, and Y.D. Livney Beta-casein nanovehicles for oral delivery of chemotherapeutic drugs Nanomed.-Nanotechnol. Biol. Med. 6 2010 119 126
5. A. Shapira, G. Markman, Y.G. Assaraf, and Y.D. Livney Beta-casein-based nanovehicles for oral delivery of chemotherapeutic drugs: drug-protein interactions and mitoxantrone loading capacity Nanomed.-Nanotechnol. Biol. Med. 6 2010 547 555
6. Y.D. Livney, A.L. Schwan, and D.G. Dalgleish A study of beta-casein tertiary structure by intramolecular crosslinking and mass spectrometry J. Dairy Sci. 87 2004 3638 3647 (Pubitemid 39474536)
7. H.E. Swaisgood Chemistry of the caseins P.F. Fox, P.L.H. McSweeney, Advanced Dairy Chemistry, Proteins Part A vol. 1 2003 Kluwer Academic/Plenum Publishers New York 139 201
8. L.M. Mikheeva, N.V. Grinberg, V.Y. Grinberg, A.R. Khokhlov, and C.G. de Kruif Thermodynamics of micellization of bovine b-casein studied by high-sensitivity differential scanning calorimetry Langmuir 19 2003 2913 2921
9. Y.S. Bae, J.W. Yang, S. Jin, S.Y. Lee, and C.H. Park Optical CDMA system using bacteriorhodopsin for optical data storage Biotechnol. Progress 15 1999 971 973
10. I. Portnaya, U. Cogan, Y.D. Livney, O. Ramon, K. Shimoni, M. Rosenberg, and D. Danino Micellization of bovine beta casein studied by isothermal titration microcalorimetry and cryogenic transmission electron microscopy J. Agric. Food. Chem. 54 2006 5555 5561 (Pubitemid 44201932)
11. J. Sakamoto, T. Matsui, and Y. Kodera Paclitaxel chemotherapy for the treatment of gastric cancer Gastric Cancer 12 2009 69 78
12. C.M.F. Kruijtzer, H. Boot, J.H. Beijnen, H.L. Lochs, F.X. Parnis, A.S.T. Planting, J.M.G. Pelgrims, R. Williams, R.A.A. Mathôt, H. Rosing, M.E. Schot, H. van Tinteren, and J.H.M. Schellens Weekly oral paclitaxel as first-line treatment in patients with advanced gastric cancer Ann. Oncol. 14 2003 197 204 (Pubitemid 36305429)
13. H. Safran, T. King, H. Choy, P. Hesketh, B. Wolf, E. Altenhein, W. Sikov, A. Rosmarin, W. Akerley, K. Radie-Keane, G. Cicchetti, F. Lopez, K. Bland, and H. Wanebo Paclitaxel and concurrent radiation for locally advanced pancreatic and gastric cancer: a phase I study J. Clin. Oncol. 15 1997 901 907 (Pubitemid 27106270)
14. C.D. Britten, S.D. Baker, L.J. Denis, T. Johnson, R. Drengler, L.L. Siu, K. Duchin, J. Kuhn, and E.K. Rowinsky Oral paclitaxel and concurrent cyclosporin A: targeting clinically relevant systemic exposure to paclitaxel Clin. Cancer. Res. 6 2000 3459 3468
15. J.H.M.S.M.M. Malingré, O Van Tellingen, M. Ouwehand, H.A. Bardelmeijer, H. Rosing, S.E. Jansen, F.J. Koopman, M.E. Schot, and W.W. Ten Bokkel Huinink The co-solvent Cremophor EL limits absorption of orally administered paclitaxel in cancer patients Br. J. Cancer 85 2001 1472 1477 (Pubitemid 34001576)
16. J. Szebeni, C.R. Alving, S. Savay, Y. Barenholz, A. Priev, D. Danino, and Y. Talmon Formation of complement-activating particles in aqueous solutions of Taxol: possible role in hypersensitivity reactions Int. Immunopharmacol. 1 2001 721 735 (Pubitemid 32206533)
17. H.H. Helgason, C.M.F. Kruijtzer, A.D.R. Huitema, S.G. Marcus, W.W. ten Bokkel Huinink, M.E. Schot, J.H. Schornagel, J.H. Beijnen, and J.H.M. Schellens Phase II and pharmacological study of oral paclitaxel (Paxoral) plus ciclosporin in anthracycline-pretreated metastatic breast cancer Br. J. Cancer 95 2006 794 800 (Pubitemid 44498092)
18. S.L.W. Koolen, J.H. Beijnen, and J.H.M. Schellens Intravenous-to-oral switch in anticancer chemotherapy: a focus on docetaxel and paclitaxel Clin. Pharmacol. Ther. 87 2009 126 129
19. D.S. Horne Casein structure, self-assembly and gelation Curr. Opin. Colloid Interface Sci. 7 2002 456 461 (Pubitemid 36007994)
20. R. Zana Dynamics in micellar solutions of amphiphilic block copolymers A.T. Hubbard, Dynamics of Surfactant Self-Assemblies 2005 CRC Press, Taylor & Francis Group New York 161 231
21. H. Gelderblom, J. Verweij, K. Nooter, and A. Sparreboom Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation Eur. J. Cancer 37 2001 1590 1598 (Oxford, England, 1990) (Pubitemid 32778603)
22. Y. Talmon Cryogenic temperature transmission electron microscopy in the study of surfactant systems B.P. Binks, Modern Characterization Methods of Surfactant Systems 1999 Marcel Dekker New York 147 178
23. D.H.T.D.J.R. Bellare, L.E. Scriven, and Y. Talmon Controlled environment vitrification system: an improved sample preparation technique J. Electron Micr. Tech. 10 1988 87 111
24. T.M. Clausen, P.K. Vinson, J.R. Minter, H.T. Davis, Y. Talmon, and W.G. Miller Viscoelastic micellar solutions: microscopy and rheology J. Phys. Chem. 96 1992 474 484
25. G. Mandalari, K. Adel-Patient, V. Barkholt, C. Baro, L. Bennett, M. Bublin, S. Gaier, G. Graser, G.S. Ladics, D. Mierzejewska, E. Vassilopoulou, Y.M. Vissers, L. Zuidmeer, N.M. Rigby, L.J. Salt, M. Defernez, F. Mulholland, A.R. Mackie, M.S.J. Wickham, and E.N.C. Mills In vitro digestibility of beta-casein and beta-lactoglobulin under simulated human gastric and duodenal conditions: a multi-laboratory evaluation Regul. Toxicol. Pharm. 55 2009 372 381
26. R.S. Christian, E.H. Schmelzera, Lucy Reynella, Renate Ulbrich-Hofmannb, Reinhard H.H. Neuberta, and KlausRaith Peptic digestion of β-casein: time course and fate of possible bioactive peptides J. Chromatogr. A 1166 2007 108 115
27. K. Paál, J. Müller, and L. Hegedûs High affinity binding of paclitaxel to human serum albumin Eur. J. Biochem. 268 2001 2187 2191 (Pubitemid 32852961)
28. J.S. Castro, P.A. Deymier, B. Trzaskowski, and J. Bucay Heterogeneous and homogeneous nucleation of Taxol (TM) crystals in aqueous solutions and gels: effect of tubulin proteins Colloids Surf. B. Biointerfaces 76 2010 199 206
29. Z.Y. Yongchun Liu, Juan Du, Xiaojun Yao, Xudong Zheng, Ruixia Lei, Jianning Liu, Huaisheng Hu, and Hong Li Interaction of Taxol with intravenous immunoglobulin: An inhibition of Taxol from crystallizing in aqueous solution Int. Immunopharmacol. 8 2008 390 400 (Pubitemid 351221430)
30. O. Soga, C.F. van Nostrum, M. Fens, C.J.F. Rijcken, R.M. Schiffelers, G. Storm, and W.E. Hennink Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery J. Controll. Release 103 2005 341 353 (Pubitemid 40342534)
31. N. Li, J. Wang, X. Yang, and L. Li Novel nanogels as drug delivery systems for poorly soluble anticancer drugs Colloids Surf. B. Biointerfaces 83 2011 237 244
32. Y. Liu, Z. Yang, J. Du, X. Yao, X. Zheng, R. Lei, J. Liu, H. Hu, and H. Li Interaction of Taxol with intravenous immunoglobul: an inhibition of Taxol from crystallizing in aqueous solution Int. Immunopharmacol. 8 2008 390 400 (Pubitemid 351221430)
33. S.J. Gong, C.J. Jin, S.Y. Rha, and H.C. Chung Growth inhibitory effects of trastuzumab and chemotherapeutic drugs in gastric cancer cell lines Cancer Lett. 214 2004 215 224 (Pubitemid 39207983)